Characteristics and Outcomes of Patients Treated With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (The Mayo Clinic Experience)

Autor: Oren, Ohad, Kludtke, Erica L., Kopecky, Stephen L.
Zdroj: In The American Journal of Cardiology 1 December 2019 124(11):1669-1673
Databáze: ScienceDirect